Ciprofloxacin
- Product NDC
- 67296-2169
- 11-digit product format
- 672962169
- Labeler code
- 67296
- Product ID
- 67296-2169_45abd636-5351-8774-e063-6294a90a558b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ciprofolxacin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Redpharm Drug
- Application
- ANDA208921
- Marketing category
- ANDA
- Marketing start
- 2023-10-01
- Substance
- CIPROFLOXACIN HYDROCHLORIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ciprofloxacin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CIPROFLOXACIN HYDROCHLORIDE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4BA73M5E37 |
| Rxcui | 197511 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-2169-1 | Ciprofloxacin | 10 in 1 BOTTLE | TABLET | 10 | | 3 |
| 67296-2169-6 | Ciprofloxacin | 6 in 1 BOTTLE | TABLET | 6 | | 3 |
| 67296-2169-7 | Ciprofloxacin | 14 in 1 BOTTLE | TABLET | 14 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67296-2169-1 | 67296216901 | 10 TABLET in 1 BOTTLE (67296-2169-1) | 10 tablet | 2023-10-01 | No | No | Historical |
| 67296-2169-6 | 67296216906 | 6 TABLET in 1 BOTTLE (67296-2169-6) | 6 tablet | 2023-10-01 | No | No | Historical |
| 67296-2169-7 | 67296216907 | 14 TABLET in 1 BOTTLE (67296-2169-7) | 14 tablet | 2023-10-01 | No | No | Historical |